{ "ok": true, "cik": "1622996", "ticker": "ACBM", "name": "ACRO BIOMEDICAL CO., LTD.", "filings": [ { "form": "8-K", "filed": "2026-09-02", "items": [ "5.02 Departure or Election of Directors; Appointment of Officers" ], "url": "https://www.sec.gov/Archives/edgar/data/1622996/000164033426001447/0001640334-26-001447-index.htm" }, { "form": "10-Q", "filed": "2026-08-14", "items": [], "url": "https://www.sec.gov/Archives/edgar/data/1622996/000164033426001345/0001640334-26-001345-index.htm" }, { "form": "10-Q", "filed": "2026-05-05", "items": [], "url": "https://www.sec.gov/Archives/edgar/data/1622996/000164033426000824/0001640334-26-000824-index.htm" }, { "form": "10-K", "filed": "2026-02-11", "items": [], "url": "https://www.sec.gov/Archives/edgar/data/1622996/000164033426000241/0001640334-26-000241-index.htm" }, { "form": "8-K", "filed": "2026-01-08", "items": [ "4.01 Changes in Registrant's Certifying Accountant", "9.01 Financial Statements and Exhibits" ], "url": "https://www.sec.gov/Archives/edgar/data/1622996/000164033426000053/0001640334-26-000053-index.htm" }, { "form": "10-Q", "filed": "2025-11-10", "items": [], "url": "https://www.sec.gov/Archives/edgar/data/1622996/000164033425001999/0001640334-25-001999-index.htm" } ], "events12m": 2, "sources": { "facts": "https://data.sec.gov/api/xbrl/companyfacts/CIK0001622996.json", "filings": "https://www.sec.gov/cgi-bin/browse-edgar?action=getcompany&CIK=1622996" }, "license": "Figures as filed with the SEC. Card text CC BY 4.0, POPS4.", "notAdvice": "Reporting, not investment advice. No price targets, no buy or sell views.", "edgar": "🫧 Edgar looked up ACRO BIOMEDICAL CO., LTD. ($ACBM). Last filing: 8-K (5.02 Departure or Election of Directors; Appointment of Officers), 2026-09-02. 2 event filings (8-K) in the past twelve months. Auditor change (8-K Item 4.01) filed 2026-01-08.", "auditor": { "changes": [ { "filed": "2026-01-08", "url": "https://www.sec.gov/Archives/edgar/data/1622996/000164033426000053/0001640334-26-000053-index.htm" }, { "filed": "2025-07-02", "url": "https://www.sec.gov/Archives/edgar/data/1622996/000164033425001097/0001640334-25-001097-index.htm" } ], "nonReliance": [], "restatedSince": null }, "metrics": { "fiscalYearEnd": "2025-12-31", "revenue": 0, "revenueGrowth1y": null, "revenueGrowthPerYear": null, "yearsOfData": 5, "operatingMargin": null, "operatingMarginPrior": null, "netMargin": null, "operatingCashFlow": -196302, "capitalSpending": null, "freeCashFlow": null, "researchAndDevelopment": null, "researchShareOfRevenue": null, "cash": 4098, "longTermDebt": null, "longTermDebtChange": null, "revenueHistory": [ { "fiscalYearEnd": "2021-12-31", "revenue": 1197500 }, { "fiscalYearEnd": "2022-12-31", "revenue": 658500 }, { "fiscalYearEnd": "2023-12-31", "revenue": 0 }, { "fiscalYearEnd": "2024-12-31", "revenue": 0 }, { "fiscalYearEnd": "2025-12-31", "revenue": 0 } ], "totalEquity": -386964, "totalAssets": 14098, "equityRatio": -27.44814867357072, "returnOnEquity": null, "dividendsPaid": null, "payoutRatio": null, "dividendPerShare": null, "dividendYearsRising": null, "dividendCut": null, "priceBased": "Dividend yield, price/earnings and price/book need a share price. The boards carry filings only, so they are not shown.", "range80": null, "ifPaceHeld": null }, "edgarette": "🔖 Exposure: revenue $0K (FY2025). Experience: one year on record; operating margin null, up from null. Soundness: equity -2744.8% of assets (liabilities exceed assets). Credibility: four or more audited years, reasonable weight. Against peers (10 filers, $50M+ revenue, services-amusement & recreation services): operating margin null against a 1.6% median.", "peers": { "sic": 7900, "sicDescription": "Services-Amusement & Recreation Services", "calendarYear": 2025, "minRevenue": 50000000, "depth": 4, "group": "7900", "growth": [ 0.106, 10 ], "opMargin": [ 0.0156, 10 ], "equityRatio": [ 0.0719, 9 ] }, "summary": "Acro Biomedical Co. (ACBM) reported revenue of $0 million in FY2025, operating margin null against a 1.6% median for services-amusement & recreation services, equity -2745% of assets. Every figure is from the company’s own annual report filed with the SEC.", "chart": "
ACRO BIOMEDICAL CO., LTD. against its own record and its peers
Equity of assetsPeer median 7.2%-2744.8%Gold tick: the median of 9–9 peers with $50M+ revenue in services-amusement & recreation services
", "chartHorizon": null, "backtest": { "tests": 4, "hits": 1, "rate": 0.25, "method": "v3", "note": "hindsight: past years, same calibrated range. The range was calibrated on 2022-2024 SEC data, so years in that window are partly in-sample." }, "caution": "Figures are as filed in audited 10-K reports and can move with restatements, acquisitions, disposals or a change in fiscal year. A range set from how past company-years turned out is not a promise about the next one, and says nothing about the share price.", "schema": "pops4.edgarette.card/1", "card": { "summary": "Acro Biomedical Co. (ACBM) reported revenue of $0 million in FY2025, operating margin null against a 1.6% median for services-amusement & recreation services, equity -2745% of assets. Every figure is from the company’s own annual report filed with the SEC.", "exposure": { "fiscalYearEnd": "2025-12-31", "revenue": 0, "totalDebt": null, "cash": 4098 }, "experience": { "revenueGrowth1y": null, "revenueGrowthPerYear": null, "operatingMargin": null, "operatingMarginPrior": null, "netMargin": null, "freeCashFlow": null }, "soundness": { "equityRatio": -27.44814867357072, "returnOnEquity": null, "payoutRatio": null, "dividendPerShare": null, "dividendYearsRising": null, "dividendCut": null, "note": "Dividend yield, price/earnings and price/book need a share price. The boards carry filings only, so they are not shown." }, "peers": { "sic": 7900, "sicDescription": "Services-Amusement & Recreation Services", "calendarYear": 2025, "minRevenue": 50000000, "depth": 4, "group": "7900", "growth": [ 0.106, 10 ], "opMargin": [ 0.0156, 10 ], "equityRatio": [ 0.0719, 9 ] }, "credibility": { "auditedYears": 5, "weight": "reasonable", "standard": "ASOP No. 25", "nonReliance": null, "auditorChange": { "filed": "2026-01-08", "url": "https://www.sec.gov/Archives/edgar/data/1622996/000164033426000053/0001640334-26-000053-index.htm" } }, "range": null, "caution": "Figures are as filed in audited 10-K reports and can move with restatements, acquisitions, disposals or a change in fiscal year. A range set from how past company-years turned out is not a promise about the next one, and says nothing about the share price.", "sources": { "facts": "https://data.sec.gov/api/xbrl/companyfacts/CIK0001622996.json", "filings": "https://www.sec.gov/cgi-bin/browse-edgar?action=getcompany&CIK=1622996" } }, "definitions": { "operatingMargin": "Operating income divided by revenue.", "netMargin": "Net income divided by revenue.", "freeCashFlow": "Cash from operations minus spending on property and equipment.", "researchShareOfRevenue": "Research and development expense for the year as a share of revenue, both as filed.", "equityRatio": "Shareholders equity as a share of total assets, both as filed. Higher means less of the company is owed to someone else.", "returnOnEquity": "Net income for the year against shareholders equity at year end.", "payoutRatio": "Dividends paid as a share of net income, in the year the cash went out.", "dividendYearsRising": "Consecutive years, counted back from the last on record, in which dividend per share rose. A fall ends the run and is reported as dividendCut.", "revenueGrowthPerYear": "Compound annual growth between the first and latest fiscal years shown.", "credibility": "How much weight a record deserves, in the actuarial sense (ASOP No. 25): more audited years, more weight.", "peers": "Medians of SEC filers with $50M+ revenue in the same industry code (SIC), narrowest group with at least 8 filers, calendar-year figures from SEC XBRL frames.", "backtest": "The same if-the-pace-held arithmetic applied to the company's own past years, scored against what it actually reported next. Hindsight, and labelled so." } }